Published in Circulation on July 04, 2000
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol (2008) 2.93
Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation (2009) 2.18
A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.17
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation (2005) 1.66
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy. Thromb J (2008) 1.03
Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007. Eur J Clin Pharmacol (2012) 0.92
Role of stenting in coronary revascularisation. Heart (2001) 0.91
Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care. Int J Cardiol (2015) 0.88
A Pocket-size Device to Detect Autonomic Neuropathy. J Diabetes Sci Technol (2008) 0.83
Glycoprotein IIb/IIIa inhibitors and acute coronary syndromes: summary report of the full submission to NICE, and beyond. Heart (2001) 0.78
A large family characterised by nocturnal sudden death. Neth Heart J (2002) 0.77
Beta blockers in heart failure haemodynamics, clinical effects and modes of action. Neth Heart J (2001) 0.75
Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin. Heart Vessels (2016) 0.75
The NVVC working group guidelines for the management of patients with non-ST-elevation acute coronary syndromes. Neth Heart J (2002) 0.75
A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population. PLoS One (2016) 0.75
Familial primary arrhythmia syndromes: Nice to know or need to know. Neth Heart J (2002) 0.75
Intensity of Left Atrial Spontaneous Echo Contrast as a Correlate for Stroke Risk Stratification in Patients with Nonvalvular Atrial Fibrillation. Sci Rep (2016) 0.75
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation. Circulation (2001) 0.75
Chronic total occlusions--a stiff challenge requiring a major breakthrough: is there light at the end of the tunnel? Heart (2005) 0.75
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89
Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med (1995) 8.52
Assessing health-related quality of life in patients with sciatica. Spine (Phila Pa 1976) (1995) 7.23
Kaposi's sarcoma. N Engl J Med (2000) 6.81
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int (2007) 6.35
Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA (1998) 6.34
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med (2001) 5.68
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05
The clinical information value of the glycosylated hemoglobin assay. N Engl J Med (1984) 4.79
Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol (1998) 4.62
Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg (2001) 4.59
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54
Effect of economic reforms on child growth in urban and rural areas of China. N Engl J Med (1996) 4.50
Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol (1997) 4.45
What is a mental/psychiatric disorder? From DSM-IV to DSM-V. Psychol Med (2010) 4.33
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13
The Maine Lumbar Spine Study, Part III. 1-year outcomes of surgical and nonsurgical management of lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 4.11
The effect of enforcing tobacco-sales laws on adolescents' access to tobacco and smoking behavior. N Engl J Med (1997) 4.06
Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation (1996) 3.88
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med (1996) 3.86
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA (1999) 3.82
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70
A current view of the interface between borderline personality disorder and depression. Am J Psychiatry (1991) 3.69
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol (1996) 3.48
Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med (1994) 3.33
Cyclin encoded by KS herpesvirus. Nature (1996) 3.32
Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care (2000) 3.26
The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry (1998) 3.26
Racial and ethnic differences in a patient survey: patients' values, ratings, and reports regarding physician primary care performance in a large health maintenance organization. Med Care (2000) 3.18
Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 3.17
Surgical and nonsurgical management of lumbar spinal stenosis: four-year outcomes from the maine lumbar spine study. Spine (Phila Pa 1976) (2000) 3.09
Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA (1998) 3.03
Glycemic control and heart failure among adult patients with diabetes. Circulation (2001) 2.99
National patterns in the treatment of smokers by physicians. JAMA (1998) 2.94
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
The Maine Lumbar Spine Study, Part II. 1-year outcomes of surgical and nonsurgical management of sciatica. Spine (Phila Pa 1976) (1996) 2.91
Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect Immun (1992) 2.80
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med (1997) 2.79
Delayed posthypoxic demyelination. Association with arylsulfatase A deficiency and lactic acidosis on proton MR spectroscopy. Neurology (1997) 2.66
Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood (1999) 2.65
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer (1995) 2.64
Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med (1997) 2.64
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med (2001) 2.60
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology (2000) 2.59
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists. JAMA (1999) 2.58
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene (1997) 2.57
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol (2000) 2.55
Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care (1999) 2.52
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS (1996) 2.49
Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia (1987) 2.44
Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med (2004) 2.42
The Quebec Task Force classification for Spinal Disorders and the severity, treatment, and outcomes of sciatica and lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 2.41
Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol (1999) 2.41
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Adult female twins' recall of childhood social class and father's education: a validation study for public health research. Am J Epidemiol (1998) 2.36
Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol (2000) 2.34
Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med (1996) 2.29
Leaving gatekeeping behind--effects of opening access to specialists for adults in a health maintenance organization. N Engl J Med (2001) 2.29
The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol (1997) 2.24
Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst (1991) 2.23
Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med (1995) 2.22
Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med (1999) 2.21
Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol (2001) 2.21
Surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: five-year outcomes from the Maine Lumbar Spine Study. Spine (Phila Pa 1976) (2001) 2.17
The leukocyte count: a predictor of hypertension. J Clin Epidemiol (1990) 2.14
Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care (1999) 2.11
The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA (1994) 2.08
Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med (1990) 2.06
Warfarin for atrial fibrillation in community-based practise. J Thromb Haemost (2008) 2.05
Comparing individual-based and household-based measures of social class to assess class inequalities in women's health: a methodological study of 684 US women. J Epidemiol Community Health (1999) 2.05
Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol (1996) 2.03
The impact of choice of muscle relaxant on postoperative recovery time: a retrospective study. Anesth Analg (1997) 2.03
Rationing intensive care--physician responses to a resource shortage. N Engl J Med (1983) 2.00
A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem (1997) 2.00
Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther (2009) 1.99